COVAX: Covid-19 Vaccines Global Access

Established:
2020 as the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator

Goals:
The equitable worldwide distribution of COVID-19 vaccines

WHO, Gavi and CEPI implemented the COVAX vaccine platform to ensure equitable global access to COVID-19 vaccines. By the end of 2021, participating countries, irrespective of their income, are expected to receive sufficient vaccines to protect the most vulnerable 20% of their populations. 190 out of around 200 countries worldwide are participating in COVAX (April 2021), consisting of 98 more prosperous countries and 92 low-to-middle-income countries.

COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, which was established by WHO, the European Commission and France. The other pillars are therapeutics and diagnostics.